Is current therapy of malignant gliomas beneficial for patients? Proteomics evidence of shifts in glioma cells expression patterns under clinically relevant treatment conditions-Reference-Cited by-同舟云学术

Is current therapy of malignant gliomas beneficial for patients? Proteomics evidence of shifts in glioma cells expression patterns under clinically relevant treatment conditions

Published:2006-05 Issue:9 Volume:6 Page:2924-2930
ISSN:1615-9853
Container-title:PROTEOMICS
language:en
Short-container-title:Proteomics

Author:

Trog Daniela,Fountoulakis Michael,Friedlein Arno,Golubnitschaja Olga

Publisher

Wiley

Subject

Molecular Biology,Biochemistry

Reference33 articles.

1. Glioblastoma multiforme and anaplastic astrocytoma pathologic criteria and prognostic implications

2. Use of two-dimensional gel electrophoresis in predictive toxicology: Identification of potential early protein biomarkers in chemically induced hepatocarcinogenesis

3. Application of fluorescence difference gel electrophoresis saturation labelling for the analysis of microdissected precursor lesions of pancreatic ductal adenocarcinoma

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. hERG channel agonist NS1643 strongly inhibits invasive astrocytoma cell line SMA-560;PLOS ONE;2024-09-06

2. Small extracellular vesicles promote invadopodia activity in glioblastoma cells in a therapy-dependent manner;Cellular Oncology;2023-04-04

3. Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells;Molecular and Cellular Biochemistry;2022-10-27

4. Inhibition of Radiation and Temozolomide-Induced Invadopodia Activity in Glioma Cells Using FDA-Approved Drugs;Translational Oncology;2018-12

5. Engineered 3D tumour model for study of glioblastoma aggressiveness and drug evaluation on a detachably assembled microfluidic device;Biomedical Microdevices;2018-09